Incannex Healthcare Inc.
IXHL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001873875
No open-market purchases or sales by Incannex Healthcare Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $1.71M in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, −6 vs. previous quarter
- 15
- 13F valueReported value at the end of Q2 2026
- $1.71M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding IXHL, Q2 2026
No superinvestor reported holding IXHL at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Incannex Healthcare Inc. insiders from Form 4, newest first.
No open-market purchases or sales by Incannex Healthcare Inc. insiders are on file.
Top 10 13F holders, Q2 2026
The largest institutional positions in Incannex Healthcare Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| LPL Financial LLC | 148,178 | $557.1K | 0.00% | +77,000+108.2% | Added |
| Millennium Management LLC | 95,252 | $358.1K | 0.00% | +95,252 | New |
| Jane Street Group, LLC | 78,195 | $294.0K | 0.00% | +78,195 | New |
| AdvisorShares Investments LLC | 60,868 | $228.9K | 0.03% | +36,365+148.4% | Added |
| Susquehanna International Group, LLP | 28,771 | $108.2K | 0.00% | +28,771 | New |
| Commonwealth Equity Services, LLC | 14,029 | $52.8K | 0.00% | +1,917+15.8% | Added |
| Citadel Advisors LLC | 10,349 | $38.9K | 0.00% | +10,349 | New |
| Advisor Group Holdings, Inc. | 6,376 | $24.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 3,610 | $13.6K | 0.00% | −36,759−91.1% | Reduced |
| Morgan Stanley | 3,558 | $13.4K | 0.00% | +1,493+72.3% | Added |